Vis enkel innførsel

dc.contributor.authorDesser, Arna S.
dc.contributor.authorOhm, Ingrid Kristine
dc.contributor.authorRose, Christopher James
dc.contributor.authorChaudhry, Fawaz Tariq
dc.contributor.authorNæss, Gunn Eva
dc.contributor.authorGiske, Liv
dc.contributor.authorFretheim, Atle
dc.date.accessioned2023-05-08T06:06:50Z
dc.date.available2023-05-08T06:06:50Z
dc.date.created2023-03-23T12:27:34Z
dc.date.issued2023
dc.identifier.isbn978-82-8406-364-5
dc.identifier.urihttps://hdl.handle.net/11250/3066668
dc.language.isoeng
dc.publisherFolkehelseinstituttet. Område for helsetjenester
dc.relation.urihttps://www.fhi.no/publ/2023/behandlinger-av-relapserende-ogeller-refraktar-myelomatose/
dc.subjectMyelomatose
dc.subject.meshThalidomide
dc.subject.meshMultiple Myeloma
dc.subject.meshBortezomib
dc.subject.meshLenalidomide
dc.subject.meshPanobinostat
dc.subject.meshPomalidomide
dc.titleTreatments for relapsing and/or refractory multiple myeloma. A health technology assessment
dc.title.alternativeBehandlinger av relapserende og/eller refraktær myelomatose: En fullstendig metodevurdering
dc.title.alternative
dc.typeResearch report
dc.description.versionpublishedVersion
dc.source.pagenumber248
dc.identifier.cristin2136402
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel